| # | Drug | Count |
|---|---|---|
| 0 | OCTREOTIDE ACETATE | 2800 |
| 1 | USTEKINUMAB | 2117 |
| 2 | ADALIMUMAB | 1264 |
| 3 | SOMATROPIN | 1054 |
| 4 | DUPILUMAB | 812 |
| 5 | ETANERCEPT | 802 |
| 6 | NALTREXONE | 784 |
| 7 | ABATACEPT | 783 |
| 8 | METFORMIN | 738 |
| 9 | METFORMIN ER 500 MG | 738 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARIPIPRAZOLE LAUROXIL | 667 | 0.1447 |
| 1 | OCTREOTIDE ACETATE | 2800 | 0.0912 |
| 2 | DIBUCAINE 1% | 10 | 0.0870 |
| 3 | GANIRELIX ACETATE | 48 | 0.0629 |
| 4 | TRIPTORELIN | 199 | 0.0593 |
| 5 | USTEKINUMAB-STBA | 21 | 0.0566 |
| 6 | PEGVISOMANT | 204 | 0.0497 |
| 7 | AMCINONIDE | 4 | 0.0471 |
| 8 | ADALIMUMAB-ADBM | 10 | 0.0373 |
| 9 | PEGFILGRASTIM-JMDB | 15 | 0.0332 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 4714 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 2629 |
| 2 | Interleukin-12 Antagonist [EPC] | 2138 |
| 3 | Interleukin-17A Antagonist [EPC] | 1170 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1050 |
| 5 | Corticosteroid [EPC] | 1028 |
| 6 | Interleukin-4 Receptor alpha Antagonist [EPC] | 812 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 783 |
| 8 | Leukocyte Growth Factor [EPC] | 660 |
| 9 | Insulin Analog [EPC] | 658 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 4714 | 0.0450 |
| 1 | Interleukin-5 Antagonist [EPC] | 26 | 0.0378 |
| 2 | Interleukin-17A Antagonist [EPC] | 1170 | 0.0314 |
| 3 | Interleukin-12 Antagonist [EPC] | 2138 | 0.0206 |
| 4 | Provitamin D2 Compound [EPC] | 575 | 0.0193 |
| 5 | Recombinant Human Growth Hormone [EPC] | 417 | 0.0190 |
| 6 | Human Immunoglobulin G [EPC] | 344 | 0.0163 |
| 7 | Interferon alfa-2b [EPC] | 30 | 0.0161 |
| 8 | GLP-2 Analog [EPC] | 189 | 0.0141 |
| 9 | Polymyxin-class Antibacterial [EPC] | 1 | 0.0137 |